|
Ok...
The test appears to have been ELISA by Quest Diagnostics. Says "Reference Range: <12.8 ng/ml"
"Result 14.0"
Looks like Triciak had Herceptin with Navelbine first, then H alone. Not sure how her2 pos she is. Biopsy and serum suggests mom has a mix of her2 pos and borderline/negative. That's what concerns me about using only a targeted therapy...especially with multiple met sites (lungs, liver). I brought up the serum test in case a broader coverage was indicated.
I'll try to keep an open mind on this for now and see if the onc gets back to us. She'll have markers on the 15th and consult/infusion on the 20th.
Doesn't Herceptin alone warrant MUGA monitoring?
|
Threaded Mode